Comparative Pharmacology
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus GUAIFENESIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus GUAIFENESIN.
AMMONIUM CHLORIDE 2.14% vs GUAIFENESIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonium chloride is an acidifying agent. It dissociates into ammonium and chloride ions. The ammonium ion is metabolized in the liver to urea and hydrogen ions, leading to metabolic acidosis. This reduces blood pH and increases renal excretion of alkaline urine.
Guaifenesin is an expectorant that increases respiratory tract fluid secretion and reduces mucus viscosity, facilitating expectoration.
For metabolic alkalosis: 1.5 to 3 g (approximately 280 to 560 mEq) intravenously over 4 to 6 hours; adjust based on serum chloride and pH.
Oral: 200-400 mg every 4 hours as needed, not to exceed 2400 mg/day.
None Documented
None Documented
4-6 hours; prolonged in renal impairment (up to 12-15 hours).
Terminal elimination half-life: 3-5 hours; clinical context: requires dosing every 4-6 hours for sustained mucolytic effect
Renal: >99% as ammonium ion and chloride; minimal biliary/fecal elimination.
Renal: ~95% (primarily as unchanged drug and glucuronide conjugate); biliary/fecal: minimal (<5%)
Category C
Category C
Expectorant/Systemic Acidifier
Expectorant